Healthequity Inc (NASDAQ:HQY) VP Ashley Dreier sold 10,000 shares of Healthequity stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $45.50, for a total transaction of $455,000.00. Following the completion of the transaction, the vice president now directly owns 15,652 shares of the company’s stock, valued at $712,166. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of Healthequity Inc (NASDAQ HQY) traded up 1.57% during mid-day trading on Friday, hitting $44.64. 698,160 shares of the stock were exchanged. The firm has a market cap of $2.68 billion, a price-to-earnings ratio of 83.91 and a beta of 1.75. The stock has a 50-day moving average price of $45.13 and a 200 day moving average price of $45.84. Healthequity Inc has a 52-week low of $30.34 and a 52-week high of $54.95.

Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.14 by $0.13. The firm had revenue of $56.90 million during the quarter, compared to analyst estimates of $55.66 million. Healthequity had a net margin of 25.31% and a return on equity of 20.36%. Healthequity’s revenue was up 28.7% on a year-over-year basis. During the same period last year, the firm posted $0.16 EPS. On average, equities research analysts expect that Healthequity Inc will post $0.70 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Ashley Dreier Sells 10,000 Shares of Healthequity Inc (HQY) Stock” was first published by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of US & international copyright laws. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/09/08/ashley-dreier-sells-10000-shares-of-healthequity-inc-hqy-stock.html.

HQY has been the subject of several recent analyst reports. BidaskClub cut shares of Healthequity from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $54.00 target price for the company in a report on Wednesday, July 12th. TheStreet raised shares of Healthequity from a “c” rating to a “b” rating in a report on Monday, July 31st. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 target price on shares of Healthequity in a report on Tuesday. Finally, Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and issued a $61.00 target price (up from $57.00) on shares of Healthequity in a report on Monday, June 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $52.13.

Several institutional investors have recently made changes to their positions in the stock. BlackRock Inc. raised its position in shares of Healthequity by 4.3% in the 2nd quarter. BlackRock Inc. now owns 5,831,014 shares of the company’s stock valued at $290,559,000 after purchasing an additional 241,061 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Healthequity by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock valued at $211,145,000 after purchasing an additional 122,061 shares during the last quarter. Wasatch Advisors Inc. raised its position in shares of Healthequity by 2.2% in the 2nd quarter. Wasatch Advisors Inc. now owns 2,442,180 shares of the company’s stock valued at $121,694,000 after purchasing an additional 52,885 shares during the last quarter. FMR LLC raised its position in shares of Healthequity by 45.6% in the 2nd quarter. FMR LLC now owns 2,235,150 shares of the company’s stock valued at $111,378,000 after purchasing an additional 699,728 shares during the last quarter. Finally, Janus Henderson Group PLC raised its position in shares of Healthequity by 627.9% in the 2nd quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock valued at $105,292,000 after purchasing an additional 1,822,732 shares during the last quarter. 91.86% of the stock is owned by hedge funds and other institutional investors.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with MarketBeat.com's FREE daily email newsletter.